Supernus Pharmaceuticals Inc. (SUPN)

56.10
NASDAQ : Health Technology
Prev Close 56.50
Day Low/High 55.30 / 56.75
52 Wk Low/High 33.30 / 59.05
Avg Volume 685.60K
Exchange NASDAQ
Shares Outstanding 51.80M
Market Cap 3.01B
EPS 1.10
P/E Ratio 40.94
Div & Yield N.A. (N.A)

Latest News

More Tax Reform Winners

More Tax Reform Winners

One way or another I continue to believe that some sort of tax legislation will be signed before the end of the year.

CVS Health, Coca-Cola, Norfolk Southern: 'Mad Money' Lightning Round

CVS Health, Coca-Cola, Norfolk Southern: 'Mad Money' Lightning Round

Jim Cramer is bullish on CVS Health, Coca-Cola, Norfolk Southern, IBM and Randgold Resources.

Victory Comes From Leadership: Cramer's 'Mad Money' Recap (Thursday 11/9/17)

Victory Comes From Leadership: Cramer's 'Mad Money' Recap (Thursday 11/9/17)

Jim Cramer says that whether it's at West Point or on Wall Street, leadership comes from loyalty, innovation, and the first-mover advantage.

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound Shares Lower After Pricing Stock Offering - Biotech Movers

MediWound priced an underwritten public offering of 4.4 million shares at $5 apiece.

Supernus Defeats Second Generic Challenger To Oxtellar XR®

Supernus Defeats Second Generic Challenger To Oxtellar XR®

Federal Court Finds Supernus Patents Valid and Infringed by TWi

UPS, McKesson, Chegg and More: 'Mad Money' Lightning Round

UPS, McKesson, Chegg and More: 'Mad Money' Lightning Round

Here's a look at what Jim Cramer had to say about companies of interest to Mad Money viewers.

Investors Should Ignore Washington: Cramer's 'Mad Money' Recap (Tuesday 7/18/17)

Investors Should Ignore Washington: Cramer's 'Mad Money' Recap (Tuesday 7/18/17)

Investors need to focus on earnings and not be distracted by the circus in Washington, Jim Cramer says.

10 Sectors That Will Profit Big-Time From Oil's Crash

10 Sectors That Will Profit Big-Time From Oil's Crash

Oil prices are tumbling down. Bad news for companies and petro states, but great news at the pump and for these ten industries...

Biotech Movers: Anika Up on Strong Analyst Ratings

Biotech Movers: Anika Up on Strong Analyst Ratings

Anika focuses on pain management, tissue regeneration and wound healing.

Short Interest In Supernus Pharmaceuticals Increases 15.4%

The most recent short interest data has been released for the 03/31/2017 settlement date, which shows a 406,576 share increase in total short interest for Supernus Pharmaceuticals Inc , to 3,053,345, an increase of 15.36% since 03/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Supernus Receives Final FDA Approval For Trokendi XR® For Migraine Prophylaxis In Adults And Adolescents

Trokendi XR is the Leading Extended-Release Topiramate Product and Brand of Topiramate

Market Goes on a 'Buy the Dip' Trip

Market Goes on a 'Buy the Dip' Trip

Stocks slowly recovering from early lows.

TheStreet Quant Rating: B+ (Buy)